| Kuiran Jiao, MD | |
|
23 Azalea Drive, Apalachin, NY 13732 | |
| (607) 220-2809 | |
| Not Available |
| Full Name | Kuiran Jiao |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 33 Years |
| Location | 23 Azalea Drive, Apalachin, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962625483 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 001236 (Georgia) | Secondary |
| 207L00000X | Anesthesiology | 4301502999 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bassett Healthcare | Cooperstown, NY | Hospital |
| Aurelia Osborn Fox Memorial Hospital | Oneonta, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bassett Healthcare | 3779488325 | 641 |
News Archive
Children and adults with social withdrawal due to Fragile X syndrome, the most common cause of inherited intellectual disability and the most common known single gene cause of autism, may benefit from an experimental drug under study by pediatric neurologists at Rush Children's Hospital at Rush University Medical Center.
Delcath Systems, Inc. announces the expansion of its global Phase 2 program for the treatment of patients with unresectable hepatocellular carcinoma (HCC) or primary liver cancer.
U.S. Department of Health and Human Services Secretary Kathleen Sebelius and Attorney General Eric Holder will discuss the Obama Administration's efforts to fight fraud using new tools provided by the Affordable Care Act at a press conference on Thursday, May 13, 2010, at 4:00 p.m. EDT. HHS and DOJ officials will also release a new report on fraud prevention and enforcement efforts.
VisEn Medical Inc., a leader in fluorescence imaging from research through medicine, announced today the commercial launch of its new GastroSense™ 750 fluorescence agent for imaging gastric motility and related drug effects in vivo.
Researchers at Duke University Medical Center (DCRI) in the United States say there is disparity in the treatment men and women receive for heart failure in hospitals.
› Verified 3 days ago
| Entity Name | Guthrie Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134178635 PECOS PAC ID: 6002728656 Enrollment ID: O20031103000220 |
News Archive
Children and adults with social withdrawal due to Fragile X syndrome, the most common cause of inherited intellectual disability and the most common known single gene cause of autism, may benefit from an experimental drug under study by pediatric neurologists at Rush Children's Hospital at Rush University Medical Center.
Delcath Systems, Inc. announces the expansion of its global Phase 2 program for the treatment of patients with unresectable hepatocellular carcinoma (HCC) or primary liver cancer.
U.S. Department of Health and Human Services Secretary Kathleen Sebelius and Attorney General Eric Holder will discuss the Obama Administration's efforts to fight fraud using new tools provided by the Affordable Care Act at a press conference on Thursday, May 13, 2010, at 4:00 p.m. EDT. HHS and DOJ officials will also release a new report on fraud prevention and enforcement efforts.
VisEn Medical Inc., a leader in fluorescence imaging from research through medicine, announced today the commercial launch of its new GastroSense™ 750 fluorescence agent for imaging gastric motility and related drug effects in vivo.
Researchers at Duke University Medical Center (DCRI) in the United States say there is disparity in the treatment men and women receive for heart failure in hospitals.
› Verified 3 days ago
| Entity Name | Mary Imogene Bassett Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083664221 PECOS PAC ID: 3779488325 Enrollment ID: O20031205000553 |
News Archive
Children and adults with social withdrawal due to Fragile X syndrome, the most common cause of inherited intellectual disability and the most common known single gene cause of autism, may benefit from an experimental drug under study by pediatric neurologists at Rush Children's Hospital at Rush University Medical Center.
Delcath Systems, Inc. announces the expansion of its global Phase 2 program for the treatment of patients with unresectable hepatocellular carcinoma (HCC) or primary liver cancer.
U.S. Department of Health and Human Services Secretary Kathleen Sebelius and Attorney General Eric Holder will discuss the Obama Administration's efforts to fight fraud using new tools provided by the Affordable Care Act at a press conference on Thursday, May 13, 2010, at 4:00 p.m. EDT. HHS and DOJ officials will also release a new report on fraud prevention and enforcement efforts.
VisEn Medical Inc., a leader in fluorescence imaging from research through medicine, announced today the commercial launch of its new GastroSense™ 750 fluorescence agent for imaging gastric motility and related drug effects in vivo.
Researchers at Duke University Medical Center (DCRI) in the United States say there is disparity in the treatment men and women receive for heart failure in hospitals.
› Verified 3 days ago
| Entity Name | Anesthesia Group Of Albany, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598700379 PECOS PAC ID: 5092602458 Enrollment ID: O20040301000885 |
News Archive
Children and adults with social withdrawal due to Fragile X syndrome, the most common cause of inherited intellectual disability and the most common known single gene cause of autism, may benefit from an experimental drug under study by pediatric neurologists at Rush Children's Hospital at Rush University Medical Center.
Delcath Systems, Inc. announces the expansion of its global Phase 2 program for the treatment of patients with unresectable hepatocellular carcinoma (HCC) or primary liver cancer.
U.S. Department of Health and Human Services Secretary Kathleen Sebelius and Attorney General Eric Holder will discuss the Obama Administration's efforts to fight fraud using new tools provided by the Affordable Care Act at a press conference on Thursday, May 13, 2010, at 4:00 p.m. EDT. HHS and DOJ officials will also release a new report on fraud prevention and enforcement efforts.
VisEn Medical Inc., a leader in fluorescence imaging from research through medicine, announced today the commercial launch of its new GastroSense™ 750 fluorescence agent for imaging gastric motility and related drug effects in vivo.
Researchers at Duke University Medical Center (DCRI) in the United States say there is disparity in the treatment men and women receive for heart failure in hospitals.
› Verified 3 days ago
| Entity Name | Premier Anesthesia Of New York, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063658961 PECOS PAC ID: 7719041102 Enrollment ID: O20090129000560 |
News Archive
Children and adults with social withdrawal due to Fragile X syndrome, the most common cause of inherited intellectual disability and the most common known single gene cause of autism, may benefit from an experimental drug under study by pediatric neurologists at Rush Children's Hospital at Rush University Medical Center.
Delcath Systems, Inc. announces the expansion of its global Phase 2 program for the treatment of patients with unresectable hepatocellular carcinoma (HCC) or primary liver cancer.
U.S. Department of Health and Human Services Secretary Kathleen Sebelius and Attorney General Eric Holder will discuss the Obama Administration's efforts to fight fraud using new tools provided by the Affordable Care Act at a press conference on Thursday, May 13, 2010, at 4:00 p.m. EDT. HHS and DOJ officials will also release a new report on fraud prevention and enforcement efforts.
VisEn Medical Inc., a leader in fluorescence imaging from research through medicine, announced today the commercial launch of its new GastroSense™ 750 fluorescence agent for imaging gastric motility and related drug effects in vivo.
Researchers at Duke University Medical Center (DCRI) in the United States say there is disparity in the treatment men and women receive for heart failure in hospitals.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kuiran Jiao, MD 23 Azalea Dr, Apalachin, NY 13732-4318 Ph: (607) 220-2809 | Kuiran Jiao, MD 23 Azalea Drive, Apalachin, NY 13732 Ph: (607) 220-2809 |
News Archive
Children and adults with social withdrawal due to Fragile X syndrome, the most common cause of inherited intellectual disability and the most common known single gene cause of autism, may benefit from an experimental drug under study by pediatric neurologists at Rush Children's Hospital at Rush University Medical Center.
Delcath Systems, Inc. announces the expansion of its global Phase 2 program for the treatment of patients with unresectable hepatocellular carcinoma (HCC) or primary liver cancer.
U.S. Department of Health and Human Services Secretary Kathleen Sebelius and Attorney General Eric Holder will discuss the Obama Administration's efforts to fight fraud using new tools provided by the Affordable Care Act at a press conference on Thursday, May 13, 2010, at 4:00 p.m. EDT. HHS and DOJ officials will also release a new report on fraud prevention and enforcement efforts.
VisEn Medical Inc., a leader in fluorescence imaging from research through medicine, announced today the commercial launch of its new GastroSense™ 750 fluorescence agent for imaging gastric motility and related drug effects in vivo.
Researchers at Duke University Medical Center (DCRI) in the United States say there is disparity in the treatment men and women receive for heart failure in hospitals.
› Verified 3 days ago